Terms: = Germ cell tumor AND CDX2, CDX3, 1045, ENSG00000165556, Q99626 AND Prognosis
19 results:
1. Clinical Approach to Neuroendocrine Neoplasm Associated With Ovarian Teratoma.
Opalińska M; Sowa-Staszczak A; Olearska H; Ulatowska-Bialas M; Gilis-Januszewska A; Hubalewska-Dydejczyk A
Front Endocrinol (Lausanne); 2021; 12():770266. PubMed ID: 34917031
[TBL] [Abstract] [Full Text] [Related]
2. Poorly differentiated neuroendocrine carcinomas of the gastrointestinal tract: A single-institute study of 43 cases.
Chen I; Zhang D; Velez M; Kovar S; Liao X
Pathol Res Pract; 2021 Oct; 226():153614. PubMed ID: 34555651
[TBL] [Abstract] [Full Text] [Related]
3. Complete remission of Cdx-2 positive primary testicular carcinoid tumor: 10-years follow-up and literature review.
Widmeier E; Füllgraf H; Waller CF
BMC Urol; 2020 Dec; 20(1):197. PubMed ID: 33317491
[TBL] [Abstract] [Full Text] [Related]
4. Retinoblastoma co-repressor 1 (RB) and cyclin-dependent kinase inhibitor (CDKN) as a multi-gene panel for differentiating pulmonary from non-pulmonary origin in metastatic neuroendocrine carcinomas.
Krishnamurthy K; Cusnir M; Schwartz M; Sriganeshan V; Poppiti RJ
Pathol Res Pract; 2020 Sep; 216(9):153051. PubMed ID: 32825935
[TBL] [Abstract] [Full Text] [Related]
5. Caudal Homeobox Gene-2 Staining Defines Intracranial Mature Teratoma with Differentiation to Colonic Adenocarcinoma.
Riedy LN; Kim M; Yun JJ; Borys E; Prabhu VC
World Neurosurg; 2019 Dec; 132():239-244. PubMed ID: 31520753
[TBL] [Abstract] [Full Text] [Related]
6. Management of neuroendocrine tumors of unknown primary.
Alexandraki K; Angelousi A; Boutzios G; Kyriakopoulos G; Rontogianni D; Kaltsas G
Rev Endocr Metab Disord; 2017 Dec; 18(4):423-431. PubMed ID: 29199361
[TBL] [Abstract] [Full Text] [Related]
7. Poorly Differentiated Medullary Phenotype Predicts Poor Survival in Early Lymph Node-Negative Gastro-Esophageal Adenocarcinomas.
Treese C; Sanchez P; Grabowski P; Berg E; Bläker H; Kruschewski M; Haase O; Hummel M; Daum S
PLoS One; 2016; 11(12):e0168237. PubMed ID: 28030564
[TBL] [Abstract] [Full Text] [Related]
8. Characteristics, treatment and outcomes of women with immature ovarian teratoma, 1998-2012.
Jorge S; Jones NL; Chen L; Hou JY; Tergas AI; Burke WM; Ananth CV; Neugut AI; Herhshman DL; Wright JD
Gynecol Oncol; 2016 Aug; 142(2):261-6. PubMed ID: 27222024
[TBL] [Abstract] [Full Text] [Related]
9. Construction and analysis of dynamic transcription factor regulatory networks in the progression of glioma.
Li Y; Shao T; Jiang C; Bai J; Wang Z; Zhang J; Zhang L; Zhao Z; Xu J; Li X
Sci Rep; 2015 Nov; 5():15953. PubMed ID: 26526635
[TBL] [Abstract] [Full Text] [Related]
10. Atypical teratoid/ rhabdoid tumor, an immunohistochemical study of potential diagnostic and prognostic markers.
Al-Hussaini M; Dissi N; Souki C; Amayiri N
Neuropathology; 2016 Feb; 36(1):17-26. PubMed ID: 26207291
[TBL] [Abstract] [Full Text] [Related]
11. Molecular and prognostic heterogeneity of microsatellite-unstable colorectal cancer.
Kim JH; Kang GH
World J Gastroenterol; 2014 Apr; 20(15):4230-43. PubMed ID: 24764661
[TBL] [Abstract] [Full Text] [Related]
12. Uveal melanoma: A pathologist's perspective and review of translational developments.
Schoenfield L
Adv Anat Pathol; 2014 Mar; 21(2):138-43. PubMed ID: 24508696
[TBL] [Abstract] [Full Text] [Related]
13. [Diagnostics and therapy for neuroendocrine neoplasia of an unknown primary - a plea for open exploration].
Begum N; Hubold C; Buchmann I; Thorns C; Bouchard R; Lubienski A; Schlöricke E; Zimmermann M; Lehnert H; Bruch HP; Bürk CG
Zentralbl Chir; 2014 Jun; 139(3):284-91. PubMed ID: 23508839
[TBL] [Abstract] [Full Text] [Related]
14. Colorectal poorly differentiated neuroendocrine carcinomas and mixed adenoneuroendocrine carcinomas: insights into the diagnostic immunophenotype, assessment of methylation profile, and search for prognostic markers.
La Rosa S; Marando A; Furlan D; Sahnane N; Capella C
Am J Surg Pathol; 2012 Apr; 36(4):601-11. PubMed ID: 22314183
[TBL] [Abstract] [Full Text] [Related]
15. Molecular pathology of gastric carcinoma.
Jang BG; Kim WH
Pathobiology; 2011; 78(6):302-10. PubMed ID: 22104201
[TBL] [Abstract] [Full Text] [Related]
16. Differentiating the undifferentiated: immunohistochemical profile of medullary carcinoma of the colon with an emphasis on intestinal differentiation.
Winn B; Tavares R; Fanion J; Noble L; Gao J; Sabo E; Resnick MB
Hum Pathol; 2009 Mar; 40(3):398-404. PubMed ID: 18992917
[TBL] [Abstract] [Full Text] [Related]
17. Expression of the intestinal transcription factor cdx2 in carcinoid tumors is a marker of midgut origin.
Jaffee IM; Rahmani M; Singhal MG; Younes M
Arch Pathol Lab Med; 2006 Oct; 130(10):1522-6. PubMed ID: 17090195
[TBL] [Abstract] [Full Text] [Related]
18. Increased WSB1 copy number correlates with its over-expression which associates with increased survival in neuroblastoma.
Chen QR; Bilke S; Wei JS; Greer BT; Steinberg SM; Westermann F; Schwab M; Khan J
Genes Chromosomes Cancer; 2006 Sep; 45(9):856-62. PubMed ID: 16804916
[TBL] [Abstract] [Full Text] [Related]
19. Alterations of G1-S checkpoint in chordoma: the prognostic impact of p53 overexpression.
Naka T; Boltze C; Kuester D; Schulz TO; Schneider-Stock R; Kellner A; Samii A; Herold C; Ostertag H; Roessner A
Cancer; 2005 Sep; 104(6):1255-63. PubMed ID: 16078265
[TBL] [Abstract] [Full Text] [Related]
